Drugs are special commodities related to human health and safety, and their production and operation should comply with the normative principles, otherwise they may gain more than they lose and be fined huge amounts
.
Recently, the alarm bell of the industry has sounded again! According to the administrative punishment information published by the Guangdong Provincial Administrative Law Enforcement Information Publicity Platform, a Chinese medicine tablet company in Huazhou City was suspected of producing inferior drugs, and after investigation, the company was fined 750,000 yuan, confiscated illegal gains, and confiscated illegal property
.
The new version of the Drug Administration Law clarifies that the scope of inferior drugs includes: the content of drug ingredients does not meet national drug standards; Contaminated medicines; Drugs whose expiration date has not been indicated or changed; Drugs that do not indicate or change the product batch number; Drugs that have exceeded their expiry date; Drugs with preservatives and excipients added without authorization; Other medicines that do not meet the standards of medicines
.
The new regulations increase the cost of violating the law on the production and sale of counterfeit and inferior drugs, stipulating that "those who produce or sell inferior drugs shall confiscate the drugs and illegal gains illegally produced and sold, and impose a fine of not less than 10 times but not more than 20 times the value of the drugs illegally produced or sold; Where the value of drugs illegally produced or wholesaled is less than 100,000 yuan, it shall be calculated as 100,000 yuan, and where the value of drugs illegally retailed is less than 10,000 yuan, it shall be calculated as 10,000 yuan; Where the circumstances are serious, order the suspension of production and business for rectification until the drug approval documents, drug production licenses, drug business licenses, or medical institution preparation licenses are revoked
.
"
Since the beginning of this year, there have been many cases of pharmaceutical companies being fined for the production and sale of inferior drugs
.
In August, the administrative penalty decision published by Credit China Showed that a pharmaceutical company was fined 100,000 yuan by the Anhui Provincial Food and Drug Administration for illegally selling inferior drugs, and the PH value of the Adapalene gel [inspection] produced by the pharmaceutical company did not meet the regulations
.
On July 27, the Sichuan Provincial Food and Drug Administration released an administrative penalty information, and a pharmaceutical company in Sichuan was punished
for selling inferior agarwood pills.
The content of the penalty shows that the pharmaceutical company was confiscated of 44.
44 yuan of illegal gains, and confiscated 208 boxes
of inferior drug agarwood pills.
In July, the Shanghai Municipal Supervision Bureau issued an administrative penalty decision showing that a Pharmaceutical Company in Shanghai had violated the law in producing inferior drugs, and the Bureau confiscated 76,645,140 yuan of illegal gains, fined 1.
5 million yuan, and confiscated illegal items
.
On April 8, the Sichuan Provincial Food and Drug Administration announced an administrative penalty information, and a Pharmaceutical Company in Sichuan was fined 300,000 yuan
for the production and sale of inferior Chinese medicine tablets and red ginseng tablets.
On March 2, the Hubei Provincial Food and Drug Administration released an administrative penalty information, in which four pharmaceutical companies in the province were punished for producing and selling inferior drugs
.
The announcement shows that these pharmaceutical companies tested unqualified drugs involving Ma Ren Pill Jing, Ye Ning Granules, Yuan Hu PainKiller Tablets, And Lu Lu Tong, and the Bureau has made penalties such as confiscating unqualified products, illegal gains and imposing fines on 4 enterprises
.
In March, a piece of administrative penalty information released by Credit Guangzhou showed that a branch of a large pharmaceutical retail enterprise was fined 100,000 yuan
for producing and selling inferior drugs.
In February, the Fujian Provincial Food and Drug Administration issued an administrative penalty information disclosure form, which publicly punished
two pharmaceutical companies.
One of them was fined 100,000 yuan
for selling the inferior drug Qin Gang.
.
.
.
.
.
.
From the perspective of punishment, the fine for the production and sale of counterfeit drugs is basically more than 100,000, which is undoubtedly a large amount of money for pharmaceutical companies, especially small and medium-sized enterprises with weak profits, reminding pharmaceutical companies not to touch the red line because of immediate interests, resulting in a situation of small and large, and enterprises can only go further
by standardizing operations.
